2008 CDA Clinical Practice Guidelines
{"Image DocumentName": "2008 CDA Clinical Practice Guidelines", "Image ImageDescription": "Clinical Assessment - Lifestyle intervention (Nutrition therapy and physical activity) A1C < 9.0% A1C \u2265 9.0% Symptomatic hyperglycemia with metabolic decompensation. Initiate metformin. Initiate pharmacotherapy immediately without waiting for effect from lifestyle interventions: Consider initiating metformin concurrently with another agent from a different class; or insulin. Initiate insulin. \u00b1 metformin. If not at target. Add an agent best suited to the individual: Alpha-glucosidase inhibitor. Incretin agent: DPP-4 inhibitor. Insulin. Insulin secretagogue: Meglitinide, Sulfonylurea. TZD. Weight loss agent. If not at target: Add another drug from a different class; or. Add bedtime basal insulin to other agent(s); or. Intensify insulin therapy CDA CPGs. Can J Diabetes 2008;32(Suppl 1):S53\u2013S61.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}